FAMFX | VISGX | FAMFX / VISGX | |
Total Expense Ratio | 1.24 | 0.19 | 653% |
Annual Report Gross Expense Ratio | 1.24 | 0.19 | 653% |
Fund Existence | 13 years | 27 years | - |
Gain YTD | -4.830 | -4.531 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500 | 3000 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 407M | 35B | 1% |
Annual Yield % from dividends | 0.00 | 0.44 | - |
Returns for 1 year | 3.62 | 7.11 | 51% |
Returns for 3 years | 23.20 | 38.50 | 60% |
Returns for 5 years | 60.33 | 40.29 | 150% |
Returns for 10 years | 59.26 | 100.60 | 59% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 118.30 | -0.61 | -0.51% |
Franklin Biotechnology Discovery A | |||
SAOIX | 30.12 | -0.19 | -0.63% |
NAA Opportunity Fund Institutional | |||
SHAPX | 35.78 | -0.37 | -1.02% |
ClearBridge Appreciation A | |||
JDPNX | 15.16 | -0.20 | -1.30% |
Janus Henderson Mid Cap Value N | |||
GGESX | 23.94 | -0.34 | -1.40% |
Nationwide Global Sust Eq Instl Svc |